{"success":true,"type":"rich","version":"1.0","cache_age":86400,"width":440,"height":500,"provider_name":"RiffReporter","provider_url":"https:\/\/www.riffreporter.de","safety":"nonadult","asset_type":"article","url":"https:\/\/www.riffreporter.de\/de\/wissen\/corona-pandemie-eindaemmen-impfstoffe-wirksamkeit-akzeptanz","category":"Wissen","author_name":"Ulrike Gebhardt","author_url":"https:\/\/www.riffreporter.de\/de\/autorinnen-und-autoren\/ulrike-gebhardt","title":"Mehr Impfstoffe und Impfdosen f\u00fcr Eind\u00e4mmung der Corona-Pandemie","summary":"Der Impferfolg h\u00e4ngt nicht nur ab von der Wirksamkeit, sondern auch von der Akzeptanz und Verf\u00fcgbarkeit der Impfstoffe.","publication_date":"31.12.2020","thumbnail_url":"https:\/\/riff.media\/images\/sars-cov-2-impfstoffe.jpg?w=440&h=247&fit=crop-50-50&s=ee6e61ea6d65b540051d0078be8950af","thumbnail_width":440,"thumbnail_height":247,"thumbnail_credit":null,"thumbnail_credit_url":null,"thumbnail_credit_note":null,"html":"<html lang=\"de\"><iframe src=\"https:\/\/riff.media\/oembed?format=html&url=https%3A%2F%2Fwww.riffreporter.de%2Fde%2Fwissen%2Fcorona-pandemie-eindaemmen-impfstoffe-wirksamkeit-akzeptanz\" width=\"440\" height=\"550\" style=\"border: 0; width: 440px; height: 550px;\" allowtransparency=\"true\" allowfullscreen><\/iframe><\/html>"}